Matthew Davis

Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia

Matthew Davis, Scott W. Johnson, Stephanie Cline et al. · Current Alzheimer Research · 2018 · 232 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

Risk of Developing Comorbidities Among Women with Endometriosis: A Retrospective Matched Cohort Study

Eric S. Surrey, Ahmed M. Soliman, Scott J. Johnson et al. · Journal of Women s Health · 2018 · 113 citations

Medicine, Gynecology, Obstetrics +10

The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US

Jasmina I. Ivanova, Howard G. Birnbaum, Seth Samuels et al. · PharmacoEconomics · 2009 · 75 citations

Pharmacy, Neurology, Pharmacoeconomics +11

Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis

David T. Rubin, Manish Mittal, Matthew Davis et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 73 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Direct costs and survival of medicare beneficiaries with early and advanced parkinson’s disease

Anna Kaltenboeck, Scott J. Johnson, Matthew Davis et al. · Parkinsonism & Related Disorders · 2011 · 65 citations

Public Affairs, Neurology, Pharmacoeconomics +11